OptiBiotix Health inks licencing agreement with Kappa Bioscience

Writer,

OptiBiotix Health said subsidiary ProBiotix Health had signed a license agreement with Kappa Bioscience.

The agreement covered the use of OptiBiotix Health's blood pressure-reducing probiotic strain Lactobacillus plantarum in a new application area within cardiovascular health.

It covered 27 countries, largely in Europe, but also included Russia and Singapore.=

At 8:51am: (LON:OPTI) Optibiotix Health Plc share price was +1p at 85p


Related content

OptiBiotix Health inks Middle East distribution pact with Prosperous Pharma

Dietary supplements company OptiBiotix Health said it had entered into a one-year exclusive distribution agreement with Lebanon-based Prosperous Pharma.

The agreement granted Prosperous exclusive rights...

Tue, 17/03/2020 - 09:45


OptiBiotix Health extends manufacturing pact with Sacco

Dietry supplements group OptiBiotix Health said subsidiary ProBiotix had signed a new global manufacturing and supply agreement with Sacco.

The pact modified and extended an...

Wed, 11/03/2020 - 09:12


OptiBiotix affirms obesity product safety status in US

Dietary supplements group OptiBiotix said it had self-affirmed that its obesity treatment product was safe to use, as per US guidelines.

The company had confirmed...

Tue, 25/02/2020 - 08:58


OptiBiotix Health inks distribution deal with Advanced NutriSolutions

Dietary supplements group OptiBiotix Health said it had signed a distribution agreement with Advanced NutriSolutions for the US and Canada.

Advanced NutriSolutions would supply OptiBiotix...

Mon, 17/02/2020 - 08:14


OptiBiotix Health inks Uruguay licencing pact for dairy products

Dietary supplements company OptiBiotix Health said subsidiary ProBiotix Health had signed a licencing agreement with Granja Pocha, extending its reach into dairy products.

The agreement...

Wed, 12/02/2020 - 13:53